222 related articles for article (PubMed ID: 32129453)
1. The Y-chromosome F haplogroup contributes to the development of Barrett's esophagus-associated esophageal adenocarcinoma in a white male population.
Westra WM; Rygiel AM; Mostafavi N; de Wit GMJ; Roes AL; Moons LMG; Peppelenbosch MP; Ouburg S; Morré SA; Jacobs M; Siersema PD; Repping S; Wang KK; Krishnadath KK
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32129453
[TBL] [Abstract][Full Text] [Related]
2. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
3. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
4. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
[TBL] [Abstract][Full Text] [Related]
5. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
6. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
7. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
9. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
14. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets for treatment of Barrett's esophagus.
Feagins LA; Souza RF
Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
[TBL] [Abstract][Full Text] [Related]
16. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
[TBL] [Abstract][Full Text] [Related]
18. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
19. Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus.
Gharahkhani P; Tung J; Hinds D; Mishra A; ; Vaughan TL; Whiteman DC; MacGregor S;
Hum Mol Genet; 2016 Feb; 25(4):828-35. PubMed ID: 26704365
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of young patients with early Barrett's neoplasia.
Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]